Table 2 Patient characteristics
From: Spatial mapping of tumor heterogeneity in whole-body PET–CT: a feasibility study
Diagnosis | Patient sex | Number of studies | Age at imaging (years) |
|---|---|---|---|
Lung cancer | Female | 63 | 64 (62) ± 9 (48–83) |
Lung cancer | Male | 101 | 67 (67) ± 9 (44–83) |
Lymphoma | Female | 68 | 45 (44) ± 20 (15–79) |
Lymphoma | Male | 75 | 48 (50) ± 18 (11–85) |
Melanoma | Female | 77 | 65 (63) ± 13 (30–95) |
Melanoma | Male | 106 | 65 (65) ± 13 (19–89) |
Negative | Female | 228 | 59 (60) ± 15 (18–84) |
Negative | Male | 274 | 59 (61) ± 16 (18–85) |